Belvedere Trading
ENZ

Belvedere Trading’s Enzo Biochem, Inc. ENZ Stock Holding History

Belvedere Trading’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-35,350
Closed -$50.5K – 1513
2022
Q4 		$50.5K Buy
+35,350
New +$68.9K ﹤0.01% 637
2021
Q4 		– Sell
-25,998
Closed -$86K – 664
2021
Q3 		$86K Buy
+25,998
New +$86.7K ﹤0.01% 372

Other funds holding ENZ

MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return
PCM
Potomac Capital Management New York $115M AUM

Belvedere Trading's ENZ Position: Q1 2023 in Review

Belvedere Trading sold out of Enzo Biochem, Inc. (ENZ) in Q1 2023, closing a stake of 35,350 shares — an estimated $50.5K sold.

Belvedere Trading first reported a position in ENZ in Q3 2021 and held it in 2 quarters. The position peaked at $86K in Q3 2021. 52 funds tracked by Wall St. Rank hold ENZ as of Q1 2023.

  • Belvedere Trading reported no remaining Enzo Biochem, Inc. position as of Q1 2023 after selling out during the quarter.
  • Belvedere Trading sold 35,350 Enzo Biochem, Inc. shares in Q1 2023, an estimated $50.5K.
  • Belvedere Trading first reported a position in Enzo Biochem, Inc. in Q3 2021 and held it in 2 quarters.
  • Belvedere Trading's Enzo Biochem, Inc. position peaked at $86K in Q3 2021.
  • 52 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q1 2023.

Based on Belvedere Trading's 13F filing for Q1 2023, filed 15 May 2023.